Diabetes Mellitus Type 1 News

• 'We Will Rock You' Into Real-time Diabetes Control Rock music could offer patients with type 1 diabetes the means to stimulate insulin release and achieve real-time diabetes control via adapted pancreatic cells and speakers, suggests a novel study.
  Medscape Medical News, December 15, 2023
• Stem Cell Therapy Implant Shows Promise for Type 1 Diabetes An experimental device containing millions of stem cells significantly reduced the need for insulin shots among people with type 1 diabetes.
  WebMD Health News, December 12, 2023
• ADA Issues New Screening, Obesity Management Recommendations Updates to the American Diabetes Association's Standards of Care for 2024 include multiple new screening recommendations, as well as new obesity management guidance and other revisions.
  Medscape Medical News, December 12, 2023
• Two Automated Insulin Delivery Systems Upgrade Tandem Diabetes Care's t:slim X2 and Beta Bionics' iLet will incorporate Dexcom G7, its latest continuous glucose monitoring system.
  Medscape Medical News, December 08, 2023
• Are Immune Therapies for Type 1 Diabetes Worthwhile? Recently published studies of two different immunologic agents show beta-cell preservation in people with newly diagnosed disease, but no differences in glycemic control and ongoing insulin requirement.
  Medscape Medical News, December 06, 2023
• Most Stop Taking Weight Loss Drugs Within 1 Year Continuation rates are higher with the new, more effective drugs, but even among those patients, more than half discontinue within a year.
  Medscape Medical News, December 06, 2023
• Cyberattacks Challenge Canadian Health Information Systems A new analysis recommends a four-stage plan for physicians and health systems to improve their cybersecurity practices.
  Medscape Medical News, November 27, 2023
• Already-Available Drug Could Help Treat Type 1 Diabetes The ornithine decarboxylase inhibitor α-difluoromethylornithine, used to treat African sleeping sickness and unwanted hair growth, may also protect β cells of people with new-onset type 1 diabetes.
  Medscape Medical News, November 20, 2023
• Does Laughter Offer Better Blood Glucose Control? People with diabetes who have a positive sense of humor appear to have better glucose control, indicates research suggesting 'humor training' could be incorporated into patient management.
  Medscape Medical News, November 14, 2023
• CBD Provides Symptom Relief and Improvement in Gastroparesis There is 'significant unmet medical need in gastroparesis,' and compared with cannabis, CBD has limited psychic effects with the added potential to reduce gut sensation and inflammation.
  MDedge News, November 13, 2023
• UnitedHealth to Add 8 Insulin Products to Reimbursement List UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket spend to $35 or less.
  Reuters Health Information, November 09, 2023
• Novo Nordisk to Discontinue Levemir Insulin in US Market Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.
  Reuters Health Information, November 08, 2023
• Assistance Dogs Benefit Patients With Various Diseases Trained dogs cannot only help patients with disabilities but also detect SARS-CoV-2 infection, cancer, and imminent epileptic seizures.
  Medscape Medical News, November 08, 2023
• Disparity Seen in Continuous Glucose Monitor Use Among Kids Children living in small, isolated rural towns had significantly lower odds of completing CGM-billed clinic visits compared with those in urban areas.
  Medscape Medical News, November 06, 2023
• Insulin Appears Less Heat-Sensitive Than Previously Thought A new Cochrane Review based on published and unpublished data finds that unopened insulin can last for up to 6 months and at temperatures up to 25°C (77°F).
  Medscape Medical News, November 02, 2023
• GoodRx to Offer Sanofi's Insulin Injection for Only $35 GoodRx said it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its digital marketplace in the US.
  Reuters Health Information, October 19, 2023
• Impaired Myocardial Flow Common in Asymptomatic Diabetes Results from myocardial perfusion imaging of 2730 people with diabetes and no known coronary disease show impaired myocardial blood flow reserve predicts mortality regardless of ischemia symptoms.
  Medscape Medical News, October 20, 2023
• Teplizumab Preserves Beta Cells in New-Onset Type 1 Diabetes Secondary endpoints including insulin use and glucose levels weren't met but trended in a positive direction.
  Medscape Medical News, October 18, 2023
• EASD 2023 New Hyperglycemia Emergency Guidance Updates DKA Definition Soon-to-be-published consensus report will remove glucose from the definition of diabetic ketoacidosis in people with diabetes, among many other changes since the last statement in 2009.
  Medscape Medical News, October 09, 2023
• Tech Improves Glycemic Outcomes in Type 1 Diabetes Pregnancy Hybrid closed-loop technology meant four times as many women spent 70% of their time in the pregnancy-specific target glucose range as the standard group, in pregnant women with type 1 diabetes.
  Medscape Medical News, October 06, 2023
• EASD 2023 Antivirals Slow Insulin Loss in New-Onset Type 1 Diabetes The combination of pleconaril and ribavirin prolonged endogenous insulin production in children and teens with new-onset type 1 diabetes.
  Medscape Medical News, October 04, 2023
• Drugmakers Sign on to Negotiate Medicare Prices Under Protest All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for Medicare said they signed on to participate in the talks by the October 1 deadline.
  Reuters Health Information, October 02, 2023
• Growing Your Patient Base With Social Media Marketing Discover how doctors market themselves and their practices on social media to connect with patients, provide accurate, thoughtful medical information, and grow their practice.
  Medscape Medical News, October 03, 2023
• Don’t Miss Type 1 Diabetes in Adults Approximately 4 in 10 cases of type 1 diabetes in adults are diagnosed at age 30 years and older, based on data from nearly 1000 individuals.
  MDedge News, September 26, 2023
• EASD 2023 EASD 2023: A Deeper Dive Into Type 1 and Type 2 Diabetes The upcoming European Association for the Study of Diabetes conference will feature fewer blockbuster trials than did the American Diabetes Association’s June meeting, but more in-depth analysis.
  Medscape Medical News, September 26, 2023
• ESC 2023 Echocardiography Boosts Prognostic Power in T1D Myocardial performance index, a heart-function metric derived from echo findings, significantly boosted the ability to predict incident CVD, especially heart failure, in people with type 1 diabetes.
  Medscape Medical News, September 21, 2023
• Call for Tighter LDL Targets for Highest Risk Patients With multiple new lipid-lowering drugs coming on the market, and European guidelines suggesting lower than ever targets in patients with very high cardiovascular risk, experts say aim for ‘ones not twos’ with low-density lipoprotein (LDL) targets.
  Medscape News UK, November 15, 2021